A historic shift in Canadian drug policy has happened, as the government allow the availability of psilocybin hallucinogens for therapeutic purposes. Until now, these substances were severely restricted, but a increasing body of research suggests they may offer benefits for psychological illnesses like PTSD. This development represents a substantia